Finally, we found the IRF2/CENP-N/AKT axis promotes malignant biological behaviors in NPC cells by increasing aerobic glycolysis, the IRF2/CENP-N/AKT signaling axis is expected to be a new target for NPC therapy. This evidence concerns the gene CENPN and nasopharyngeal carcinoma.